Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid

Cellular and Molecular Biology

Volumn 51, Issue 2, 2005, Pages 229-238

  Johnson, J ^a   Hunter, R ^a   McElveen, R ^a   Qian, X H ^b   Baliga, B S ^b   Pace, B S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Fetal hemoglobin; Gamma globin; Histone deacetylase inhibitor; p38 MAPK; Scriptaid

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; GAMMA GLOBIN; HEMOGLOBIN F; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROID PRECURSOR CELL; GENE SILENCING; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RETICULOCYTOSIS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANEMIA, SICKLE CELL; ANIMALS; BUTYRATES; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; FETAL HEMOGLOBIN; GENE EXPRESSION REGULATION; GENE SILENCING; GLOBINS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; HYDROXYLAMINES; IMIDAZOLES; K562 CELLS; MICE; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; QUINOLINES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 30644464660     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Atweh, G.F., DeSimone, J., Saunthararajah, Y., Fathallah, H., Weinberg, R.S., Nagel, R.L., Fabry, M.E. and Adams, R.J., Hemoglobinopathies. Hematology. Am. Soc. Hematol. Educ. Program. 2003: 14-39.
2. Atweh, G.F., Sutton, M., Nassif, I., Boosalis, Y., Dover, G.J., Wallenstein, S., Wright, E., McMahon, L., Stamatoyannopoulos, G., Faller, D.V. and Perrine, S.P., Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 1999, 93: 1790-1797.
3. Baliga, B.S., Pace, B.S., Chen, H., Shah, A.K. and Yang, Y., Mechanism for induction of fetal hemoglobin synthesis by hydroxyurea in sickle cell erythroid progenitors. Am. J. Hematol. 2000, 65: 227-233.
4. Bohan, C., Robinson, R.A. and Luciw, P.A., Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology 1989, 172: 573-583.
5. Bouchain, G. and Delorme, D., Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation. Curr. Med. Chem. 2003, 10: 2359-2372.
6. Bovenzi, V. and Momparler, R.L., Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Cancer Chemother. Pharmacol. 2001, 48: 71-76.
7. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. and Baylin, S.B., Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999, 21: 103-107.
8. Cao, H., Stamatoyannopoulos, G. and Jung, M., Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 2004, 103: 701-709.
9. Charache, S., Dover, G., Smith, K., Talbot, C.C. Jr., Moyer, M. and Boyer. S., Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc. Natl. Acad. Sci. USA 1983, 80: 4842-4846.
10. Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. and Schechter, A.N., Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J. Clin. Invest. 2003, 111: 231-239.
11. Collins, A.F., Pearson, H.A., Giardina, P., McDonagh, K.T., Brusilow, S.W. and Dover, G.J., Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood 1995, 85: 43-49.
12. Conrad, P.W., Rust, R.T., Han, J., Milhorn, D.E. and Beitner-Johnson, D., Selective activation of p38α and p38γ by hypoxia. J. Biol. Chem. 1999, 274: 23570-23576.
13. Curenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T., Young, P.R. and Lee, J.C., SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS. Lett. 1995, 64: 229-233.
14. Davie, J.R., Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133: 2485S-2493S.
15. Deng, G., Song, G.A., Pong, E., Sleisenger, M. and Kim, Y.S., Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res. 2004, 64: 2692-2698.
16. DeSimone, J., Koshy M., Dorn, L., Lavelle, D., Bressler, L., Molokie, R. and Talischy N., Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. Blood 2002, 99: 3905-3908.
17. Dobson, M.E. and Ingram, V.M., In vitro transcription of chromatin containing histones hyperacetylated in vivo. Nucl. Acids Res. 1980, 8: 4201-4219.
18. Enslen, H., Raingeaud, J. and Davis, R.J., Selective activation of p38 mitogen-acitvated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 1998, 3: 741-1748.
19. Fang, X., Han, H., Stamatoyannopoulos, G. and Li, Q., Developmentally specific role of the CCAAT box in regulation of human gamma-globin gene expression. J. Biol. Chem. 2004, 279: 5444-5449.
20. Gabbianelli, M., Testa, U., Massa, A., Pelosi, E., Sposi, N.M., Riccioni, R., Luchetti, L. and Peschle, C., Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood 2000, 95: 3555-3561.
21. Glauber, J.G., Wandersee, N.J., Little, J.A. and Ginder, G., 5′ flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol. Cell. Biol. 1991, 11: 4690-4697.
22. Gozzini, A., Rovida, E., Sbarba, P., Galimberti, S., Santini, V. and Galimbert, S., Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. Cancer Res. 2003, 63: 8955-8961.
23. Gustin, J.A., Pincheira, R., Mayo, L.D., Ozes, O.N., Kessler, K.M., Baerwald, M.R., Korgaonkar, C.K. and Donner, D.B., Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells. Am. J. Physiol. Cell. Physiol. 2004, 286: C547-555.
24. Hashimshony T., Zhang, J., Keshet, I., Bustin, M. and Cedar, H., The role of DNA methylation in setting up chromatin structure during development. Nat. Genet. 2003, 34: 187-192.
25. Haynes, J.H., Baliga, B.S., Obiako B., Ofori-Acquah, S.F. and Pace, B.S., Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of 12-lipoxygenase and nitric oxide. Blood 2004, 103: 3945-3950.
26. He, H. and Lehming, N., Global effects of histone modifications. Brief Funct. Genomic Proteomic 2003, 2: 234-243.
27. Ikuta, T., Kan, Y.W., Swerdlow, P.S., Faller, D.V. and Perrine, S.P., Alterations in protein-DNA interactions in the γ globin gene promoter in response to butyrate therapy. Blood 1998, 92: 2924-2933.
28. Jacobs-Helber, S.M., Ryan, J.J. and Sawyer, S.T., JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood 2000, 96: 933-940.
29. Keen, J.C., Yan, L., Mack, K.M., Pettit, C., Smith, D., Sharma, D. and Davidson, N.E., A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine. Breast Cancer Res. Treat. 2003, 81: 177-186.
30. Komatsu, N., Watanabe, T., Uchida, M., Mori, M., Kirito, K., Kikuchi, S., Liu, Q., Tauchi, T., Miyazawa, K., Endo, H., and Nagai, T. and Ozawa, K., A member of forkhead transcription factor FKHRL1 is a downstream effector of SXI571-induced cell cycle arrest in BCR-ABL-expressing cells. J. Biol. Chem. 2003, 278: 6411-6419.
31. Kouzarides, T., Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet Dev. 1999, 9: 40-48.
32. Kruh, J., Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 1982, 42: 65-82.
33. Liu, C. and Xu, D., Inhibition of histone deacetylases. Meth. Mol. Biol. 2004, 287: 87-97.
34. McCaffrey, P.G., Newsome, D.A., Fibach, E., Yoshida, M. and Su, M.S., Induction of gamma-globin by histone deacetylase inhibitors. Blood 1997, 90: 2075-2083.
35. Morton, S., Davis, R.J. and Cohen, P. Signaling pathways involved in multisite phosphorylation of the transcription factor AXF-2. FEBS. Lett. 2004, 572: 177-183.
36. Nishino, N., Jose, B., Shinta, R., Kato, T., Komatsu, Y. and Yoshida, M., Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors. Bioorg. Med. Chem. 2004, 12: 5777-57784.
37. Nishio, H. and Walsh, M.J., CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. Proc. Natl. Acad. Sci. USA 2004, 101: 11257-11262.
38. Norton, V.G., Imai, B.S., Yau, P. and Bradburg, E.M., Histone acetylation reduces nucleosome core particle linking number change. Cell 1989, 57: 449-457.
39. Pace, B., Li, Q., Peterson, K. and Stamatoyannopoulos, G., α-Amino butyric acid fails to reactivate the totally silenced γ gene of the β locus YAC. Blood 1994, 4: 4344-4353.
40. Pace, B.S., Chen, Y.R., Thompson, A. and Goodman, S.R., Butyrate inducible elements in the human Aγ globin gene promoter. Exp. Hematol. 2000, 28: 283-293.
41. Pace, B.S., Qian, X.H., Sangerman, J., Ofori-Acquah, S.F., Baliga, B.S., Han, J. and Critz, S.D., p38 MAP kinase activation mediates γ-globin gene induction in erythroid progenitors. Exp. Hematol. 2003, 31: 1089-1096.
42. Pace, B.S., White, G.I., Dover, G.J., Boosalis, M.S., Thies, A. and Perrine, S.P., Short chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood 2002, 100: 4640-4648.
43. Park, J.I., Choi, H.S., Jeong, J.S., Han, J.Y. and Kim, I.H., Involvement of p38 Kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ. 2001, 12: 481-486.
44. Paszty C., Brian, C.M., Manci, E., Witkowska, H.E., Stevens, M.E., Mohandas, N. and Rubin, E.M., Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 1997, 278: 876-878.
45. Perrine, S.P., Ginder, G.D., Faller, D.V., Dover, G.H., Ikuta, T., Witkowska, H.E. Cai, S.P., Vichinsky, E.P. and Oliveri, N.F., A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N. Engl. J. Med. 1993, 328: 81-86.
46. Perrine, S.P., Ginder, G.D., Faller, D.Y., Dover, G.H., Ikuta, T., Witkowska, H.E., Cai, S.P., Vichinsky, E.P. and Olivieri, N.F., A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N. Engl. J. Med. 1993, 328: 81-86.
47. Peterson, K.R., Clegg, C.H., Huxley, C., Josephson, B.M., Haugen, H.S., Furukawa, T. and Stamatoyannopoulos, G., Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes. Proc. Natl. Acad. Sci. USA 1993, 90: 7593-7597.
48. Raingeaud, J., Whitemarsh, A.J., Barrett, T., Derijard, B. and Davis, R.J., MKK3- and MKK6-regulated gene expression is mediated by p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996, 16: 1247-1252.
49. Roux, P.P. and Blenis, J., ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68: 320-344.
50. Ryan, T.M., Ciavatta, D.J. and Townes, T.M., Rnockout-transgenic mouse model of sickle cell disease. Science 1997, 278: 873-876.
51. Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T. and Nakanishi, O., A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 1999, 96: 4592-4597.
52. Saunthararajah, Y., Lavelle, D. and DeSimone, J., DNA hypomethylating agents and sickle cell disease. Br. J. Haematol. 2004, 126: 629-636.
53. Skarpidi, E., Cao, H., Heltweg, B., White, B.F., Marhenke, R.L., Jung, M. and Stamatoyannopoulos, G., Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression. Exp. Hematol. 2003, 31: 197-203.
54. Su, G.H., John, T.A., Ryu, B. and Kern, S.E., A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. Cancer Res. 2000, 60: 3137-3142.
55. Uddin, S., Ah-Kang, J., Ulaszek, J., Mahmud, D. and Wickrema, A., Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc. Natl. Acad. Sci. USA 2004, 101: 147-152.
56. Wierenga, A.T.J., Vogelzang, I., Eggen, B.J. and Vallenga, E., Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp. Hematol. 2003, 31: 398-405.
57. Witt, O., Monkemeyer, S., Kanbach, K. and Pekrun, A., Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways. Am. J. Hematol. 2002, 71: 45-46.
58. Witt, O., Monkemeyer, S., Ronndahl, G., Erdlenbruch, B., Reinhardt, D., Kanbach, K. and Pekrun, A., Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 2003, 101: 2001-2007.
59. Witt, O., Sand, K., and Pekrun, A., Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000, 95: 2391-2396.
60. Xu, L., Ferry, A.E., Monteiro, C. and Pace, B.S., Increased globin production by antisense globin RNA transcripts. Gene Ther. 2000, 7: 438-444.
61. Yee, S.B., Kim, M.S., Baek, S.J., Kim, G.C., Yoo, K.S., Yoo, Y.H. and Park, B.S., Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion. Int. J. Oncol. 2004, 25: 1431-1436.
62. Yoshida, M., Matsuyama, A., Komatsu, Y. and Nishino, N., From discovery to the coming generation of histone deacetylase inhibitors. Curr. Med. Chem. 2003, 10: 2351-2358.